Home » Newsletters » BioWorld Science

BioWorld Science

July 3, 2001

View Archived Issues

Clinical candidate for thrombotic diseases selected by Takeda from dibasic gpIIb/IIIa antagonists

COX-2 inhibitor, leukotriene receptor antagonist and their combination useful for migraine

Further study of zonisamide for migraine/headache prophylaxis appears appropriate

NexMed launches Befar in China

Liver-targeted complexes of cisplatin and bile acids designed by Spanish group

Myocardin, a novel cardiac regulatory gene with potential for heart muscle regeneration

ImClone Systems begins fast track approval process for colorectal cancer agent

Additional beneficial effects emerge for SERM Sch-57068 (EM-652) in preclinical studies

Barr and Duramed agree to merge

Metabolex/Pfizer diabetes partnership gains new focus

SafeScience to create joint venture with Elan for phase II anticancer agent

Exclusivity period for human gene therapeutic consortium expires

Roche licenses levovirin from ICN

ADA news: glycemic control and lipid profiles improve on INS-1 + sulfonylurea in type 2 diabetes

Org-25935 dose-dependently increases striatal glycine levels in rats

Small-molecule LFA-1 antagonist enters phase I studies

CollaGenex launches tablet formulation of Periostat

Novavax seeks approval of Estrasorb in U.S.; expands license agreement with King

New AGE production inhibitor with promise in diabetic nephropathy

NeoTherapeutics adds site to Neotrofin SCI study

Recent patent reveals novel antifungal, antiprotozoal sordaricin derivatives

Selective beta3-adrenoceptor agonists designed at Kissei

Pyrimidine-based inhibitors of CD40 function reported by Sankyo

Brain subtype-specific nicotinic receptor agonists and uses thereof described by Targacept

Potent chymase inhibitors presented by Wakunaga

AHP develops potential anxiolytic and antidepressant agents

Takeda describes heterocyclic compounds that inhibit T-cell proliferation and IL-2 production

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...